Retatrutide met the primary endpoints in each trial at 80 weeks, delivering powerful weight loss along with significant improvements in knee osteoarthritis pain and obstructive sleep apnea
Manrique C, Habibi J, Aroor AR, Sowers JR, Jia G, Hayden MR, Garro M, Martinez-Lemus LA, Ramirez-Perez FI, Klein T, et al
What We Know So Far Despite growing interest in Ozempic and male fertility, there are still significant gaps in the data
Long-term studies are ongoing to establish the full safety profile of the drug
infarct size) expressed as the percentage of area at risk, as described 13,14
If youre considering GLP-1 therapy as part of your weight loss or metabolic health journey, Dr